Bal Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 15.92 Cr
- Company Age 37 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 168.75 Cr
- Satisfied Charges ₹ 177.04 Cr
- Revenue Growth 13.83%
- Profit Growth -5.70%
- Ebitda -11.84%
- Net Worth 10.09%
- Total Assets 10.73%
About Bal Pharma
Bal Pharma Limited (BPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 May 1987 and has a history of 37 years and nine months. Its registered office is in Bangaluru, Karnataka, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524824 and on the National Stock Exchange(NSE) under BALPHARMA.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 15.92 Cr.
The company currently has active open charges totaling ₹168.75 Cr. The company has closed loans amounting to ₹177.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bal Pharma Limited India are Abdul Basith as COMPANY SECRETARY and Daddanala Bhushan as Cfo. Shailesh Siroya, H Venkatesh, Nicola Neeladri, and Three other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Bal Pharma Limited offer?
Bal Pharma Limited offers a wide range of products and services, including Kids, Racing Bicycles and Rickshaws, Sports Bicycles, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Health Conditions, Respiratory Care, Skin Care, Sanitizers & Handwash.
Who are the key members and board of directors at Bal Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Siroya  | Managing Director | 01-Aug-2004 | Current |
| Abdul Basith | Company Secretary | 17-Jul-2023 | Current |
| Daddanala Bhushan | CFO | 08-Mar-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| H Venkatesh | Director | 23-May-2020 | Current |
| Nicola Neeladri | Director | 23-May-2020 | Current |
| Kotian Damodar | Whole-Time Director | 30-May-2022 | Current |
| Himesh Virupakshaya | Whole-Time Director | 28-Sep-2019 | Current |
| Jatish Sheth | Director | 28-Dec-2020 | Current |
Financial Performance of Bal Pharma.
Bal Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.83% increase. The company also saw a slight decrease in profitability, with a 5.7% decrease in profit. The company's net worth Soared by an impressive increase of 10.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bal Pharma?
In 2022, Bal Pharma had a promoter holding of 49.57% and a public holding of 50.43%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Isg Novasoft Technologies LimitedNicola Neeladri is a mutual person
Kaunshya Investments Private LimitedShailesh Siroya is a mutual person
Lifezen Healthcare Private LimitedShailesh Siroya is a mutual person
Mro-Tek Realty LimitedH Venkatesh and Nicola Neeladri are mutual person
Wildcraft India LimitedH Venkatesh is a mutual person
Balance Clinics LlpShailesh Siroya is a mutual person
Charges (Loans)
₹168.75 Cr
₹177.04 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 96.33 Cr
- Canara Bank : 58.78 Cr
- Others : 9.35 Cr
- Sidbi : 4.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2024 | Hdfc Bank Limited | ₹0.69 M | Open |
| 08 Jan 2024 | Others | ₹1.08 Cr | Open |
| 29 Dec 2023 | Hdfc Bank Limited | ₹0.56 M | Open |
| 06 Dec 2023 | Sidbi | ₹4.29 Cr | Open |
| 29 May 2023 | Hdfc Bank Limited | ₹3.20 M | Open |
How Many Employees Work at Bal Pharma?
Bal Pharma has a workforce of 812 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
